Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecules, drug products, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.
Research context
Zhejiang Jiuzhou Pharmaceutical Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Zhejiang Jiuzhou Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 22.8% above its 200 day moving average.
From a valuation standpoint, the stock is 37.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 13.2.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd's total revenue rose by 47.5% to $738M since the same quarter in the previous year.
Its net income has increased by 231.4% to $110M since the same quarter in the previous year.
Finally, its free cash flow grew by 1972.4% to $282M since the same quarter in the previous year.
Based on the above factors, Zhejiang Jiuzhou Pharmaceutical Co., Ltd gets an overall score of 4/5.